October 31

2018

Placing Investment Bets on Biomedical Breakthroughs in the 21st Century Requires Patience

21st Century Tech

Home
News
Placing Investment Bets on Biomedical Breakthroughs in the 21st Century Requires Patience

Related People

David S. Bakst

Corporate & Securities Partner David Bakst (New York) is quoted in this article.

Related Capabilities

Practices –

Corporate & Securities

Industries –

Life Sciences

News

July 05

2022

Mayer Brown advised Preem on more than $2.2 billion of Credit Facilities and High Yield Bonds
June 30

2022

Mayer Brown adds Private Equity partner Paul Rosen to its Corporate & Securities practice in London
June 28

2022

Mayer Brown advises on sale of Extra MSA Group
June 22

2022

Mayer Brown advises leading fresh chicken brand Foster Farms on sale to private equity firm Atlas Holdings
June 21

2022

Martha McGarry named among The Deal’s 2022 “Top Women in Dealmaking”